• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·002872.SZ
Share

Tiansheng Pharmaceutical Group Co., Ltd. Stocks

CN¥ 4.98Last Updated 16.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

CN¥ 229.02M

CN¥ 4.98
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Tiansheng Pharmaceutical Group Co., Ltd. is engaged in the manufacturing and distribution of pharmaceutical products. The company supplies a broad spectrum of medications that address various therapeutic areas, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, oncological, hepatobiliary, hematological, surgical, and diabetic conditions, among others. This enterprise was established in 2001 and its headquarters are located in Chongqing, China.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.07.2026 07:30

Netflix is expecting a slowdown in revenue growth for the second consecutive quarter. Its stock plummeted 8%.

17.07.2026 02:57

The release of Google's cutting-edge AI model has been delayed by months — Bloomberg. Shares fell

17.07.2026 01:40

Alphabet and other tech stocks dragged down the entire market: the Nasdaq index fell 1.5%

17.07.2026 01:10

Trump Media will charge traders for quick access to Trump's posts

17.07.2026 00:31

Cathie Wood bought SpaceX shares during a dip ahead of a new Starship rocket test

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026